Shield Therapeutics Share Discussion Threads

[paleje] 15/12/2020 23:47

Ask the the questions tomorrow, all the awkward ones, if he doesnt answer or lies hiding behind 'confidentiality' etc then we know we've got a problem. But let's see.

There's still time to ask, the more the better imo.

[siriusbizness] 15/12/2020 23:06

Many different deals in the US can now be made following this strategy

[parc1] 15/12/2020 20:46

"it's just a matter of 14 months" and no deal - and now Shield are trying to go it alone raising $40million. They knew full well what the situation was and let it drag on this long. 14 months cannot be justified to suddenly and completely change tack.

We are not talking about expecting "any deal will do" and "just a matter of time".
This deal has demised, it is no more, it has ceased to be. It has expired and gone to meet its maker. It is late, bereft of life.

[siriusbizness] 15/12/2020 20:25

Sounds like some want a deal at any price. Perhaps a deal hasn’t completed because it’s not realising good value for the shareholders. Europe has a deal, China has a deal...it’s just a matter of time now for the US. The business case for a deal hasn’t met the lowest acceptable outcome abs hence going it alone is more profitable for all shareholders. As I said before nothing has changed except the timeline and investors are growing impatient. This price is a steal and so I’m loading up

[parc1] 15/12/2020 19:05

I stand by my opinion of the product.

Ferracru is ground-breaking and a game changer. A fantastic product.

I just cannot understand why Shield has not been able to bring a US distributor on board - and that is because information has been withheld. Tim Watts should have been
transparent and lack of transparency is deceit. It is not acceptable behaviour. He has set the scene for the company under his "control".

He needs to go.

His presentation only needs one word: "goodbye"

[innittowinit] 15/12/2020 17:39

@850

If that had been happening it would have had to have been formalised with the company's advisors and then if not successful, the market would have had to have been cleansed by a specific RNS. THat has happened.

[siriusbizness] 15/12/2020 16:28

I’m buying more here at 61p. I’ll continue to add if it drops into the 40s/50s as it didn’t hang around long there last time. Nothing has changed with the product so some form of deal is still there to be had. It really did sound like the deal was there but fell apart at the end.

[onceaday] 15/12/2020 15:41

If it is really such a great opportunity in the USA then perhaps that's where they need to look for funding. US investors are unlikley to know about the historical "hiccups" along the way and it might give them the chance of a clean slate.

[best1467] 15/12/2020 14:53

Well I’ll see if I can get order filled at 55p

[ramnik007] 15/12/2020 14:39

Would not surprised if CEO been discussing fund raise to institutions and some have decided to bail out.

[smithless] 15/12/2020 14:31

On a positive, at least someone has picked up this line of stock at 55p, which they would have though was a good discounted price, so hopefully near bottom

[innittowinit] 15/12/2020 14:07

Through the negotiations that STX has been having presumably big pharma has already looked and passed. Perhaps at this stupid price it sparks interest for a low ball bid that is just enough to entice WHealth? If they agree to a sale then it is done in reality. Bit like the Norgine proposition.

If the ex-CEO has been a seller of significant shares today I guess he is thinking that as he has no input/control over the decisions and presumably he has a very concentrated position (or he is really very wealthy from other sources that his position in STX is not material to him), he needs to protect against the risk of further downside and even a heavily discounted 'bird in hand' is better than deeper erosion of his long fought for value.

In the end we all have our own reasons for buying or selling and we cannot control other peoples actions, so it is what it is.

I guess he gets classed as a retail/private investor and the shares must surely have been bought by an institutional investor, which surely is a positive. Perhaps that purchase will lead also to a TR1 and we can discover which one it is.

Presumably these big sales will remove any overhang also which should be another positive for remaining holders.

[nobbygnome] 15/12/2020 14:00

>> the provosts

FWIW I don't think it will ever come to that although I can understand why it might worry some people. However, it appears most of the required amount would be debt finance which is not as bad as equity funding.

I still expect a US deal......if they are not taken over before that comes to pass. I am certain multiple companies are running the rule over them right now as the value is clear to see.

[peachie 74] 15/12/2020 13:51

Whoever that sell was and for whatever reason, it’s done. And although the management maybe viewed as failures, the opportunity for this drug worldwide is huge.
A sitting duck atm surely for a big Pharma.

[theprovosts] 15/12/2020 13:49

Nobby, assuming it was this statement that did not impress the market?

"the costs of Shield's current non-US operations and the ongoing paediatric study is in the range of $30 million to $40 million. The Company expects that any financing for a Shield led US launch of Accrufer® would include a substantial debt component and Shield is in discussions with several potential lenders and has already received a number of term sheets on acceptable commercial terms."

However, once finalized im sure the equity can be valued more accurately?

[peachie 74] 15/12/2020 13:48

Agreed Nobby

[filthy rich] 15/12/2020 13:35

Well said Nobby. It's an excellent buying opportunity. My portfolio is full of them ;)

[whatno] 15/12/2020 13:20

I guess we will get an RNS in due course but probably the ex-CEO. I think that confirms his view of his ex-CFO's abilities!

[lako42] 15/12/2020 13:07

7m sell. What a mess this has become.

[paleje] 15/12/2020 12:57

Parob,

No, on what we've heard recently I don't think it should be TW behind the wheel but I want to hear what he's got to say tomorrow and how he answers questions and how many he avoids.

Good luck if you're still in.

[nobbygnome] 15/12/2020 12:54

People sell for a variety of reasons. Just use your own cognitive abilities to assess what an approved drug is worth. Look at the market cap of other companies such as SAR or VAL which are years away from having a drug. For me it's absolutely stark and once this pre disappointment indigestion is out of the way this will rerate to at least £1.